Latest Updates on Lipid Management
- PMID: 30877603
- DOI: 10.1007/s40292-019-00306-8
Latest Updates on Lipid Management
Abstract
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.
Keywords: ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides.
Similar articles
-
Lipid update 2020 - Introduction and foreword.Prog Cardiovasc Dis. 2019 Sep-Oct;62(5):373-374. doi: 10.1016/j.pcad.2019.11.006. Epub 2019 Nov 9. Prog Cardiovasc Dis. 2019. PMID: 31711789 No abstract available.
-
The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future.Prog Cardiovasc Dis. 2019 Sep-Oct;62(5):375-383. doi: 10.1016/j.pcad.2019.11.005. Epub 2019 Nov 13. Prog Cardiovasc Dis. 2019. PMID: 31733217 Review.
-
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.J Clin Lipidol. 2015 Mar-Apr;9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7. J Clin Lipidol. 2015. PMID: 25911072
-
Counterpoint: Low-Density Lipoprotein Cholesterol Targets Are Not Needed in Lipid Treatment Guidelines.Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):586-90. doi: 10.1161/ATVBAHA.116.306887. Epub 2016 Mar 17. Arterioscler Thromb Vasc Biol. 2016. PMID: 26988588
-
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):32-40. doi: 10.1016/j.pcad.2015.05.004. Epub 2015 May 9. Prog Cardiovasc Dis. 2015. PMID: 25968932 Free PMC article. Review.
Cited by
-
Rosuvastatin protects against endothelial cell apoptosis in vitro and alleviates atherosclerosis in ApoE-/- mice by suppressing endoplasmic reticulum stress.Exp Ther Med. 2020 Jul;20(1):550-560. doi: 10.3892/etm.2020.8733. Epub 2020 May 8. Exp Ther Med. 2020. PMID: 32537013 Free PMC article.
-
Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.Biomedicines. 2021 Nov 27;9(12):1783. doi: 10.3390/biomedicines9121783. Biomedicines. 2021. PMID: 34944600 Free PMC article.
-
Lipid-lowering Therapies in Myositis.Curr Rheumatol Rep. 2020 Aug 26;22(10):70. doi: 10.1007/s11926-020-00942-3. Curr Rheumatol Rep. 2020. PMID: 32845379 Free PMC article. Review.
-
Ginsenoside Rg3 Alleviates ox-LDL Induced Endothelial Dysfunction and Prevents Atherosclerosis in ApoE-/- Mice by Regulating PPARγ/FAK Signaling Pathway.Front Pharmacol. 2020 Apr 22;11:500. doi: 10.3389/fphar.2020.00500. eCollection 2020. Front Pharmacol. 2020. PMID: 32390845 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical